CPIG
BBH icon

Chicago Partners Investment Group’s VanEck Biotech ETF BBH Stock Holding History

Chicago Partners Investment Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-600
Closed -$75K – 919
2017
Q4 		$75K Buy
+600
New +$76.6K 0.01% 396

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Chicago Partners Investment Group's BBH Position: Q1 2018 in Review

Chicago Partners Investment Group sold out of VanEck Biotech ETF (BBH) in Q1 2018, closing a stake of 600 shares — an estimated $75K sold.

Chicago Partners Investment Group first reported a position in BBH in Q4 2017 and held it in 1 quarter. The position peaked at $75K in Q4 2017. 82 funds tracked by Wall St. Rank hold BBH as of Q1 2018.

  • Chicago Partners Investment Group reported no remaining VanEck Biotech ETF position as of Q1 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 600 VanEck Biotech ETF shares in Q1 2018, an estimated $75K.
  • Chicago Partners Investment Group first reported a position in VanEck Biotech ETF in Q4 2017 and held it in 1 quarter.
  • Chicago Partners Investment Group's VanEck Biotech ETF position peaked at $75K in Q4 2017.
  • 82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2018.

Based on Chicago Partners Investment Group's 13F filing for Q1 2018, filed 27 Apr 2018.